F-fucoidan-related compounds (Takara)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameF-fucoidan-related compounds (Takara)
Drug Alias NameU-fucoidan (Takara)
ClassificationNatural product/ExtractSmall molecules > Carbohydrate > Oligosaccharide
Mechanisms of ActionHepatocyte growth factor receptor agonistsSelectins modulators
TargetsSelectinsHepatocyte growth factor receptor
Therapy Area/IndicationsPulmonary FibrosisLiver CirrhosisLiver Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTakara Shuzo
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTakara ShuzoNxera Pharma Co Ltd
Active IndicationsN/A
Inactive IndicationsPulmonary FibrosisLiver CirrhosisLiver Diseases +[4] 

Other Information

ATC CodeN/A
Related LinksN/A